PLC ("TC BioPharm" or the "Company")  a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced an update on ...
This study presents important findings on the role of CXXC-finger protein 1 in regulatory T cell gene regulation and function. The evidence supporting the authors' claims is solid, with mostly ...
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some HIV-positive individuals ... that signal neighboring cells to heighten their ...
The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...
There is a simple discount patient access scheme for alectinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
Called Vance, the global, multinational, randomised phase three trial, led by Singapore clinician-scientist Toh Han Chong, is the largest completed trial on T-cell therapy on any solid tumour.
Xenetic (XBIO) Biosciences announced the presentation of positive preclinical data. The poster titled ... Both published and newer data suggests that DNase I impedes neutrophil tumor infiltration, ...
The work is published in the journal Nature Communications. For some years now, CAR-T cells have been bringing new momentum to immunotherapies against cancer. How it works: experts take the ...
The CD4 count is a test that measures how many CD4 cells you have in your ... of becoming very ill if they don’t start HIV treatment. Anyone who is HIV-positive should take antiretroviral ...
These memory cells, which include special CD4+ (CD4 positive) T-cells, contain information about which antigens it has encountered ... Broadly neutralising antibodies potentially benefit immune ...
Yadira Caraveo on Saturday evening in Colorado’s 8th Congressional District, but the winner of the race — which could determine whether the GOP has unified control over the federal government — likely ...